NL-OMON54293招募中不适用
*Screening for Albuminuria at the first line for early identification of chronic kidney disease - SALINE
General Practitioners Research Institute0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diabetes Mellitus (diagnosis or prescription for the disease based on the NHG
- •guidelines)
- •Adipositas (diagnosis)
- •Hypertension (diagnosis or prescription for the disease based on the NHG
- •guidelines)
- •Cardiovascular disease (diagnosis, specified in protocol section 4.2.2)
- •Lipid disorder (diagnosis or prescription for the disease based on the NHG
- •guidelines)
- •Age 45-80 years
排除标准
- •Inability to write or understand the informed consent form
- •Known normal (<3mg/mmol) albuminuria status within 18 months prior
研究者
相似试验
已完成
不适用
Towards HOMe-based Albuminuria Screening: an implementation study testing two approachesCardiovasular disease100110821002914910003216kidney diseaseNL-OMON50434niversitair Medisch Centrum Groningen15,032
已完成
不适用
Screening for Albuminuria at the First Line for Early Identification of CKDChronic Kidney DiseasesAlbuminuriaNCT05321095General Practitioners Research Institute141
进行中（未招募）
不适用
ow grade albuminuria: reaching a new target for irbesartaEUCTR2007-000501-29-DEniversity Hospital of Erlangen40
尚未招募
不适用
Rotation for Optimal Targeting of Albuminuria and Treatment EvaluatioType 2 diabetes and albuminuriaNL-OMON26322niversity Medical Center Groningen52
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetic and non diabetic Chronic Kideny DiseaseEUCTR2017-004641-25-ESniversity Medical Center Groningen46